RTW INVESTMENTS, LP
Institutional investor · Portfolio as of Q1 2021
Top Holdings111 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
ROCKET PHARMACEUTICALS INC | 15.7M | $697.3M | 10.9% | $18.09 | +139.57% | 9 qtrssince 2019-Q1 | Decreased 0 |
STATE STREET SPDR S&P 500 ETF TRUST CL USD INC | 946,255 | $375M | 5.9% | $369.68 | 0.00% | 1 qtr | New 96 |
VERICEL CORP | 4.5M | $251M | 3.9% | $17.25 | +205.24% | 9 qtrssince 2019-Q1 | Unchanged 0 |
PTC THERAPEUTICS INC | 5.3M | $250.7M | 3.9% | $41.64 | +12.39% | 9 qtrssince 2019-Q1 | Increased 69 |
ALNYLAM PHARMACEUTICALS INC | 1.7M | $237.7M | 3.7% | $81.30 | +66.22% | 9 qtrssince 2019-Q1 | Increased 56 |
MIRATI THERAPEUTICS INC | 1.3M | $228.4M | 3.6% | — | — | 9 qtrssince 2019-Q1 | Increased 70 |
DICERNA PHARMACEUTICALS INC | 7.5M | $190.8M | 3.0% | — | — | 9 qtrssince 2019-Q1 | Increased 54 |
ILLUMINA INC | 481,956 | $185.1M | 2.9% | $334.66 | +7.25% | 3 qtrssince 2020-Q3 | Increased 67 |
NATERA INC | 1.7M | $173.9M | 2.7% | $37.29 | +160.50% | 7 qtrssince 2019-Q3 | Unchanged 0 |
DERMTECH INC | 3.1M | $158.4M | 2.5% | — | — | 7 qtrssince 2019-Q3 | Increased 56 |
ESTABLISHMENT LABS HLDGS INC | 2.3M | $145M | 2.3% | $21.90 | +172.85% | 9 qtrssince 2019-Q1 | Unchanged 0 |
STOKE THERAPEUTICS INC | 3.6M | $141.5M | 2.2% | $29.30 | +26.44% | 8 qtrssince 2019-Q2 | Increased 53 |
MASIMO CORP | 594,956 | $136.6M | 2.1% | $172.07 | +31.42% | 9 qtrssince 2019-Q1 | Increased 64 |
10x Genomics Inc Class A | 711,515 | $128.8M | 2.0% | $86.08 | +95.43% | 7 qtrssince 2019-Q3 | Increased 56 |
CERNER CORP | 1.8M | $127.6M | 2.0% | — | — | 4 qtrssince 2020-Q2 | Increased 50 |
AXONICS INC | 1.9M | $112.8M | 1.8% | — | — | 9 qtrssince 2019-Q1 | Unchanged 0 |
QUIDEL CORP | 878,533 | $112.4M | 1.8% | $126.39 | 0.00% | 1 qtr | New 69 |
ARVINAS INC | 1.6M | $107.3M | 1.7% | $82.53 | -24.21% | 2 qtrssince 2020-Q4 | Decreased 0 |
GLOBUS MED INC | 1.7M | $103M | 1.6% | $64.85 | -5.82% | 2 qtrssince 2020-Q4 | Increased 48 |
IMMUNOVANT INC | 6.4M | $102M | 1.6% | $22.69 | -33.88% | 6 qtrssince 2019-Q4 | Decreased 0 |
RTW INVESTMENTS, LP manages $6.4B across 111 positions as of Q1 2021. Top holdings: RCKT (10.9%), SPY (5.9%), VCEL (3.9%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2.5/5.0.
Active quarter - 18 new positions, 9 exits, 32 increased. Top move: SPY (NEW, conviction 96). Portfolio: $6.4B across 111 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer